Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Zurich
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female and male patients with chronic PTSD due to adult trauma; PTSD is diagnosed according to the DSM-IV, as measured with the CAPS
Age between 18 and 60
You may not be if
History of disease states representing contraindications to glucocorticoid therapy (tuberculosis, gastritis, gastric- and duodenal ulcers, Cushing's disease, osteoporosis, hypertension, pregnancy (to exclude with a pregnancy test) and lactation, glaucoma, diabetes mellitus, thrombophilia, acute or chronic infections, hyperthyroidism, cirrhosis)
Severe or chronic somatic diseases
Topic glucocorticoid therapy (for large skin parts)
Inhaled glucocorticoids
Current psychotic, bipolar, substance-related, or severe personality disorder
Current severe depressive disorder
Severe cognitive impairment or a history of organic mental disorder
Evidence of PTSD or depression immediately prior to the index trauma
Prominent current suicidal or homicidal ideation
Asylum seeking status
Body weight \>20% above or below normal range
Changes in psychopharmacologic or psychotherapeutic management less than 8 weeks before start of the study
Clareo Health | Low-dose Cortisol in Chronic Posttraumatic Stress Disorder
